The disclosure relates to systems and methods for the storage and transportation of bodily tissue.
The current invention generally relates to devices, systems, and methods for extracorporeal preservation of bodily tissue. Extracorporeal preservation of bodily tissue is essential in transplant procedures so that donor tissue can be transported to a recipient in a remote location. In order to provide the best graft survival rates, donor tissues must be matched to appropriate recipients. Because of the sudden nature of most tissue donation events, appropriate recipients must be rapidly located and must be within a limited geographic area of the donor. Time limitations on the extracorporeal viability of donor tissue can lead to less than ideal tissue matching and, worse, wasted donor tissue. Prolonging the viability of donor tissue can allow for better matching between donor tissue and recipients and, in turn, can increase graft survival rates and increase availability of donor tissue to the growing waitlists of individuals in need of transplants.
The most prevalent current technique for preserving a bodily tissue for transplantation is static cold storage. While hypothermic temperatures decrease the oxygen demand of the bodily tissue, the tissue's viability is still time-limited by insufficient oxygen levels to meet the tissue's decreased metabolic needs. An example of static cold storage is shown in
Another storage and transport system is shown in
A major limitation of hypothermic storage techniques, including those shown in
Systems and methods of the invention are directed to increasing donor tissue viability during and after storage and transport. In particular, systems and methods relate to storage and transport of organs with increased pressure. Systems and methods of the invention recognize that increased pressure, combined with controlled, hypothermic temperatures reduce organ edema or swelling during transport and thereby improve the condition of organs at implantation. Organ containers described herein include perfusion and static systems using rigid containers similar to those shown in
Methods of the invention include filling the container from an elevated source of preservation fluid. Elevating the fluid source and purging air from the container results in an increased pressure in the system just as water pressure increases at greater depths in the ocean. However, due to the relative incompressibility of the fluid and the lack of flexibility in the container, there is little ability using existing techniques to capture and retain that pressure once the system has been filled.
Systems and methods of the invention include the addition of various pressurizing elements added to the container system to introduce a compressible element and, thereby capture and maintain the pressure developed during filling of the container throughout storage and transport.
Various pressurizing elements are contemplated including in-line pressurizers with spring-energized bellows, elastomeric balloons, or floating spring or gas-energized bellows. Any capable of introducing an element of increased volumetric compliance into the otherwise rigid container system can be used. In certain embodiments, the container may be plastic but inelastic such that the container becomes rigid as it is completely filled with preservation fluid.
Aspects of the invention include methods for loading an organ into and filling a container of the invention in order to apply pressure to the stored organ. Methods include using a container with a purge port at the highest level of the container to allow all air to escape and to be replaced with fluid during filling. Such containers are described, for example, and as noted above, in U.S. Pat. No. 9,426,979. Fluid can be added to the container through a fill line and can be added at a desired pressure (e.g., 25 to 50 cm H2O) for organ storage and transport. The line pressure can be maintained through, for example, a pump or compressor, or, as in preferred embodiments, through elevation of the fluid source above the container during filling. A fill valve in the line can be opened during filling and, once all air has been purged and the pressurizer has been energized (e.g., expanded to accommodate the fill pressure), can be closed to create a fluid-tight system within the container at an increased pressure. The pressurizer must resist expansion such that its resistance maintains the pressure in the system. After the fill valve has been closed and the system sealed, the fill line can be disconnected from the sealed container system and the organ is ready for transport.
In certain embodiments, the desired pressure range is between about 25 to about 50 cm H2O (equivalent to 18.4-36.8 mmHg, 0.36-0.71 psig, or 0.024-0.048 atm). The pressure may vary according to the type, size, and condition of the organ. In order to create and maintain pressures in the above ranges using an elevated fluid source, that source can be suspended 50 cm or more above the container during filling procedures. Pressurized systems can be operable to counteract osmotic pressure in the preservation fluid or in the stored tissue. Accordingly, edema can be reduced. In various embodiments, the relationship of osmotic pressure to the pressure in the preservation fluid can be manipulated to drive preservation fluid into the tissue, draw fluid out of the tissue, or maintain a desired fluid level in the tissue (e.g., to prevent edema).
Systems and methods of the invention have application in both static cold storage devices and hypothermic machine perfusion devices. In certain embodiments, hypothermic machine perfusion devices are configured to oxygenate and perfuse a bodily tissue for extracorporeal preservation of the bodily tissue. The perfusion apparatuses can include a pneumatic system, a pumping chamber, and an organ chamber. The pneumatic system may be configured for the controlled delivery of fluid to and from the pumping chamber based on a predetermined control scheme. The predetermined control scheme can be, for example, a time-based control scheme or a pressure-based control scheme. The pumping chamber is configured to diffuse a gas into a perfusate and to generate a pulse wave for moving the perfusate through a bodily tissue. The organ chamber is configured to receive the bodily tissue and the perfusate. The organ chamber is configured to substantially automatically purge excess fluid from the organ chamber to the pumping chamber. The pumping chamber may be configured to substantially automatically purge excess fluid from the pumping chamber to an area external to the apparatus.
Devices, systems and methods are described herein that are configured for extracorporeal preservation and transportation of bodily tissue. Specifically, devices and methods for creating and maintaining pressure within organ storage and transport containers are described. Systems and methods can be used to reduce edema in transported organs by maintaining an increased pressure in the surrounding fluid to prevent swelling by applying a compressive force to the organ. It is thought that the increased pressure further approximates the internal conditions of the human body to which the organ is usually subjected, thereby prolonging organ viability during storage and transport.
A controlled thermal environment can be maintained for the organ through the use of a rigid container completely filled with preservation fluid and purged of air. Systems can be filled with fluid at an increased pressure derived from mechanical pumping or through elevation of the fluid source. In order to adjust and maintain a desired pressure in the range of about 25 to about 50 cm H2O given a rigid container and a relatively incompressible fluid within the container, systems and methods of the invention use a pressurizer to introduce a desired level of volumetric compliance. The resistance to compression in bellows-type pressurizers or to expansion in balloon-type pressurizers can be selected to achieve and maintain the desired pressure within the system. The resistance can manipulated as a function of material choice, spring-rate, gas volume (e.g., in gas-energized bellows) to achieve the desired pressure within the system.
The system may use any of a number of cooling media to maintain the temperature inside an insulated transport container during transport. Cooling media may comprise eutectic cooling blocks, which have been engineered to have a stable temperature between 2-10° C., for example. The cooling media can be arranged in recesses in the interior of the insulated vessel. The recesses may be a slot or the recess may be a press-fit, or the cooling media may be coupled to the walls of the insulated vessel using a snap, screw, hook and loop, or another suitable connecter. Eutectic cooling media suitable for use with the invention is available from TCP Reliable Inc. Edison, N.J. 08837, as well as other suppliers. Other media, such as containerized water, containerized water-alcohol mixtures, or containerized water-glycol mixtures may also be used. The container need not be rigid, for example the cooling media may be contained in a bag which is placed in the recess. Using the cooling media, e.g. eutectic cooling blocks, the invention is capable of maintaining the temperature of the sample in the range of 2-10° C. for at least 60 minutes, e.g., for greater than 4 hours, for greater than 8 hours, for greater than 12 hours, or for greater than 16 hours.
In various embodiments, cooling blocks may include eutectic cooling media or other phase change material (PCM) such as savENRG packs with PCM-HS01P material commercially available from RGEES, LLC or Akuratemp, LLC (Arden, N.C.). Exemplary PCM specifications including a freezing temperature of 0° C.+/−0.5° C., a melting temperature of 1° C.+/−0.75° C., latent heat of 310 J/g+/−10 J/g, and density of 0.95 gram/ml+/−0.05 gram/ml. Pouch dimensions may vary depending on application specifics such as tissue to be transported and the internal dimensions of the transport container and external dimensions of the tissue storage device, chamber, or canister. PCM may be included in pouches approximately 10 inches by 6 inches having approximately 230 g of PCM therein. Pouches may be approximately 8.5 mm thick and weigh about 235 g to 247 g. In some embodiments, pouches may be approximately 6.25 inches by 7.75 inches with a thickness of less than about 8.5 mm and a weight of between about 193 g and about 201 g. Other exemplary dimensions may include about 6.25 inches by about 10 inches. Pouches may be stacked or layered, for example in groups of 3 or 4 to increase the total thickness and amount of PCM. In certain embodiments, PCM containing pouches may be joined side to side to form a band of coupled PCM pouches. Such a band may be readily manipulated to wrap around the circumference of a cylindrical storage container and may have dimensions of about 6 inches by about 26 inches consisting of approximately 8 individual pouches joined together in the band. Pouches may be formed of a film for containing the PCM having a desirable moisture vapor transmission rate to avoid PCM mass loss over time. Suitable films include X2030 EVOH and nylon pouch film available from Protect-all (Darien, Wis.) and pluss plain laminate 162μ OP nylon multilayer film 350 mm available from Shrinath Rotopack Pvt. Ltd. (India).
As shown in
In order to generate and maintain greater pressure (above the 8-20 cm H2O observed in rigid canisters such as shown in
Two components can be added to a purging canister transport system such as shown in
An exemplary pressurizer element is shown in
The bellows may rely on inherent shape memory in the material of the bellows itself to provide resistance to expansion or compression or may use, for example, springs opposing the expansion or compression of the bellows via compression or tension. Any known spring type may be used including coiled materials or elastic bands to provide expansion resistance. The expansion- or compression-resisting force may be a single rate or may be progressive or adjustable. In various embodiments, a constant force spring can be used to maintain system pressure. Constant force springs are springs for which the force they exert over their range of motion is relatively constant. Constant force springs may be constructed from rolled ribbons of, for example, spring steel.
In certain embodiments, the pressurizer can, instead of passively maintaining pressure, be used to actively create pressure by, for example, manually compressing a bellows-type pressurizer, filling the container with fluid, sealing the container, and manually releasing the compressed pressurizer. The pressurizer can thereby create additional pressure above the in-line pressure of the fill fluid.
An exemplary filling procedure according the certain methods is illustrated in
During set-up in
Once the vent port is closed, pressure will be allowed to build within the system to equal the in-line pressure caused by the elevated fluid source. The pressurizer will thereby be energized, expanding (or compressing in other embodiments) in response to the force of the fluid pressure within the system. Once the pressurizer is energized, the fill valve can be closed, thereby sealing the system and maintaining a pressure within the container equal to the in-line pressure from the elevated fluid source through the spring-energized resistance of the pressurizer. A pressure gauge can be positioned along the system (e.g., on the canister, on the fill line, or in the pressurizer to allow for monitoring and management of the internal pressure in the canister during set up and transport. In certain embodiments, the pressurizer may be variably compliant (e.g., have an externally adjustable spring rate) to allow pressure to be changed within the system after the container is filled and sealed.
After the fill valve is closed, the fill line to the fluid source can be disconnected and the container is ready for transport.
Materials for valves and pressurizers, wherever surfaces may contact the preservation fluid or the organ to be transported, should be selected based on biocompatibility and inertness with respect to the preservation fluid. Considerations such as sterility and ability to be sterilized are also used in material selection.
References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.
Various modifications of the invention and many further embodiments thereof, in addition to those shown and described herein, will become apparent to those skilled in the art from the full contents of this document, including references to the scientific and patent literature cited herein. The subject matter herein contains important information, exemplification and guidance that can be adapted to the practice of this invention in its various embodiments and equivalents thereof
This application is a continuation-in-part of PCT Application Ser. No. PCT/US2020/047324, filed Aug. 21, 2020, which claims the benefit of and priority to U.S. Provisional Patent Application Ser. No. 62/890,877, filed Aug. 23, 2019, the content of each of which is incorporated herein in its entirety.
Number | Date | Country | |
---|---|---|---|
62890877 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2020/047324 | Aug 2020 | US |
Child | 17473836 | US |